Barrett Katz - Feb 2, 2022 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
Chief Medical Officer
Signature
/s/ Lara Meisner, Attorney-in-Fact for Barrett Katz
Stock symbol
VRDN
Transactions as of
Feb 2, 2022
Transactions value $
$0
Form type
4
Date filed
2/3/2022, 05:13 PM
Next filing
Jan 11, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRDN Stock Option (Right to Buy) Award $0 +110K $0.00 110K Feb 2, 2022 Common Stock 110K $18.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in equal monthly installments through February 2, 2026, subject to the Reporting Person's continued service to Issuer through each vesting date.

Remarks:

Exhibit 24 - Power of Attorney